Dimopoulos P, Mulita A, Antzoulas A, Bodard S, Leivaditis V, Akrida I
Prz Gastroenterol. 2025; 19(3):221-230.
PMID: 39802971
PMC: 11718495.
DOI: 10.5114/pg.2024.143147.
Skrip L, Moosburner S, Tang P, Guo J, Gorner S, Tzschatzsch H
J Transl Med. 2024; 22(1):774.
PMID: 39152426
PMC: 11328469.
DOI: 10.1186/s12967-024-05559-z.
Meyblum L, Faron M, Deschamps F, Kobe A, Bonnet B, Boileve A
Eur Radiol. 2024; 35(2):1022-1033.
PMID: 39080068
DOI: 10.1007/s00330-024-10887-1.
Esmail A, Badheeb M, Alnahar B, Almiqlash B, Sakr Y, Al-Najjar E
Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065760
PMC: 11279608.
DOI: 10.3390/ph17070910.
Yang X, Liao Y, Fan L, Lin B, Li J, Wu D
PLoS One. 2024; 19(7):e0306595.
PMID: 38968190
PMC: 11226133.
DOI: 10.1371/journal.pone.0306595.
Surgical Resection in Colorectal Liver Metastasis: An Umbrella Review.
Milazzo M, Todeschini L, Caimano M, Mattia A, Cristin L, Martinino A
Cancers (Basel). 2024; 16(10).
PMID: 38791928
PMC: 11120322.
DOI: 10.3390/cancers16101849.
Targeting Liver Metastases to Potentiate Immunotherapy in MS-Stable Colorectal Cancer-A Review of the Literature.
Zlotnik O, Krzywon L, Bloom J, Kalil J, Altubi I, Lazaris A
Cancers (Basel). 2023; 15(21).
PMID: 37958384
PMC: 10649257.
DOI: 10.3390/cancers15215210.
The predictive value of liver tests for the presence of liver metastases.
Kimchy A, Singh H, Parikh E, Rosenberg J, Sanghavi K, Lewis J
Hepat Oncol. 2023; 10(3):HEP48.
PMID: 37885607
PMC: 10599222.
DOI: 10.2217/hep-2023-0003.
Redo Pelvic Surgery and Combined Metastectomy for Locally Recurrent Rectal Cancer with Known Oligometastatic Disease: A Multicentre Review.
Keogh C, OSullivan N, Temperley H, Flood M, Ting P, Walsh C
Cancers (Basel). 2023; 15(18).
PMID: 37760439
PMC: 10527388.
DOI: 10.3390/cancers15184469.
Multidisciplinary discussion and management of synchronous colorectal liver metastases: A single center study in China.
Li H, Gu G, Li S, Yan Y, Hu S, Fu Z
World J Gastrointest Oncol. 2023; 15(9):1616-1625.
PMID: 37746642
PMC: 10514728.
DOI: 10.4251/wjgo.v15.i9.1616.
Predicting Limited Survival After Resection of Synchronous Colorectal Liver Metastases: a Propensity Score Matched Comparison Between The Primary First And The Simultaneous Strategy.
Addeo P, Foguenne M, Guerra M, Cusumano C, Paul C, Faitot F
J Gastrointest Surg. 2023; 27(6):1141-1151.
PMID: 36857012
DOI: 10.1007/s11605-023-05633-9.
Survival Outcomes of Optimally Treated Colorectal Metastases: The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease.
Solsky I, Moaven O, Valenzuela C, Lundy M, Stauffer J, Del Piccolo N
Ann Surg Oncol. 2023; 30(7):4264-4273.
PMID: 36754944
DOI: 10.1245/s10434-023-13174-3.
Simultaneous versus staged major hepatectomy (≥3 liver segments) for outcomes of synchronous colorectal liver metastases: A systematic review and meta-analysis.
Liu J, Xia Y, Pan X, Yan Z, Zhang L, Yang Z
Cancer Rep (Hoboken). 2022; 5(8):e1617.
PMID: 35753719
PMC: 9351651.
DOI: 10.1002/cnr2.1617.
Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma.
Franssen S, Soares K, Jolissaint J, Tsilimigras D, Buettner S, Alexandrescu S
JAMA Surg. 2022; 157(7):590-596.
PMID: 35544131
PMC: 9096688.
DOI: 10.1001/jamasurg.2022.1298.
HBV Infection Status Indicates Different Risks of Synchronous and Metachronous Liver Metastasis in Colorectal Cancer: A Retrospective Study of 3132 Patients with a 5-Year Follow-Up.
Zhou J, Guo X, Huang P, Tan S, Lin R, Zhan H
Cancer Manag Res. 2022; 14:1581-1594.
PMID: 35509873
PMC: 9059988.
DOI: 10.2147/CMAR.S350276.
Characterization of genomic alterations in Chinese colorectal cancer patients with liver metastases.
Wang H, Yan X, Wang L, Zhang M, Yang C, Wei-Liu
J Transl Med. 2021; 19(1):313.
PMID: 34281583
PMC: 8287676.
DOI: 10.1186/s12967-021-02986-0.
Interventional Treatment for Cholangiocarcinoma.
Li H, Chen L, Zhu G, Yao X, Dong R, Guo J
Front Oncol. 2021; 11:671327.
PMID: 34268114
PMC: 8276166.
DOI: 10.3389/fonc.2021.671327.
Development and validation of survival nomograms in colorectal cancer patients with synchronous liver metastases underwent simultaneous surgical treatment of primary and metastatic lesions.
Guo X, Liu Y, Liu L, Li J, Zhao L, Jin X
Am J Cancer Res. 2021; 11(6):2654-2669.
PMID: 34249420
PMC: 8263634.
Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases.
Srouji R, Narayan R, Boerner T, Buisman F, Seier K, Gonen M
J Surg Oncol. 2020; 122(8):1536-1542.
PMID: 32976666
PMC: 7938716.
DOI: 10.1002/jso.26221.
Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial.
Vogl T, Marko C, Langenbach M, Naguib N, Filmann N, Hammerstingl R
Eur Radiol. 2020; 31(4):2242-2251.
PMID: 32960329
DOI: 10.1007/s00330-020-07253-2.